NYSE$HR
Healthcare Realty Trust Inc · Q4 2025 earnings
Q4 2025 earnings · · After market close · Investor relations
Briefing
HR reported Q4 2025, revenue of $274.7M, net income of $14.4M, diluted EPS of $0.04.
For Q4 2025, HR reported revenue of $274.7M, net income of $14.4M, diluted EPS was $0.04. Management discusses segment performance, capital allocation, and outlook in the earnings release.
- Revenue $274.7M.
- Net income $14.4M.
- Diluted EPS $0.04.
Headline financials
Revenue & EPS history
Healthcare Realty · Revenue · Quarterly
$275M
Revenue by segment
Healthcare Realty · $4.26M total across 1 segment · Q3 2023
- Interest Income$4.26M+26.7%100.0%
Forward guidance
The release discusses HR's outlook for upcoming periods, including capital allocation, operating priorities, and market risks.
Tailwinds
- HR cites operational execution and demand trends supporting the outlook.
- Balance sheet and capital actions aim to fund growth and shareholder returns.
Headwinds
- Macro, pricing, and input-cost volatility could pressure margins.
- Segment mix and one-time items may affect quarter-to-quarter comparability.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2025
-0.6%
Avg return
Earnings day
+0.1%
Avg return
5 days after
-0.2%
Avg return
30 days after
45%
29 / 65 earnings
Positive
+5.8%
Q3 2022
Best reaction
-10.1%
Q4 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +2.9% | +8.2% | +6.6% | |
| Q4 2025 | +2.7% | +3.1% | +2.8% | |
| Q3 2025 | -0.6% | +1.0% | +2.6% | |
| Q1 2025 | -4.4% | -4.3% | -8.7% | |
| Q4 2024 | -1.3% | -1.0% | -2.2% | |
| Q3 2024 | -5.3% | -5.1% | +1.0% | |
| Q2 2024 | -0.3% | +0.8% | +1.7% | |
| Q1 2024 | +2.1% | +2.5% | +10.2% | |
| Q4 2023 | -10.1% | -8.8% | -17.8% | |
| Q3 2023 | +1.1% | -1.1% | +5.1% | |
| Q2 2023 | -6.0% | -8.5% | -15.3% | |
| Q1 2023 | -1.5% | +0.6% | -1.4% | |
| Q4 2022 | +0.7% | -4.0% | -5.9% | |
| Q3 2022 | +5.8% | +0.4% | +0.6% | |
| Q2 2022 | +3.6% | +3.9% | -4.0% | |
| Q1 2022 | -0.2% | -2.4% | -9.8% | |
| Q4 2021 | -8.8% | -4.5% | -5.2% | |
| Q3 2021 | +1.2% | +1.8% | -0.9% | |
| Q2 2021 | -2.6% | -0.5% | -2.3% | |
| Q1 2021 | +2.5% | +0.8% | -1.4% | |
| Q4 2020 | +0.4% | +0.7% | -0.3% | |
| Q3 2020 | +4.6% | +7.3% | +3.8% | |
| Q2 2020 | +1.6% | -1.6% | +2.8% | |
| Q1 2020 | +4.0% | +9.2% | +10.0% | |
| Q4 2019 | +1.2% | +1.8% | -6.3% | |
| Q3 2019 | -6.6% | -7.4% | -4.6% | |
| Q2 2019 | -1.1% | -0.6% | +2.2% | |
| Q1 2019 | -0.4% | +0.3% | +4.4% | |
| Q4 2018 | +2.0% | +2.7% | +0.4% | |
| Q3 2018 | -1.3% | +2.5% | +11.3% | |
| Q2 2018 | +2.7% | +4.1% | +4.0% | |
| Q1 2018 | +1.8% | +1.2% | +0.4% | |
| Q4 2017 | -2.1% | -0.8% | -1.5% | |
| Q3 2017 | +0.4% | +1.3% | +2.9% | |
| Q2 2017 | +0.3% | -0.3% | +0.5% | |
| Q1 2017 | -1.5% | +1.0% | +7.3% | |
| Q4 2016 | +2.7% | +2.8% | +3.4% | |
| Q3 2016 | -3.6% | -1.4% | -5.5% | |
| Q2 2016 | +0.3% | -0.6% | -0.5% | |
| Q1 2016 | +0.6% | — | — | |
| Q4 2015 | -1.4% | — | — | |
| Q3 2015 | -0.7% | — | — | |
| Q2 2015 | -0.2% | — | — | |
| Q1 2015 | +0.0% | — | — | |
| Q4 2014 | +2.0% | — | — | |
| Q3 2014 | -0.3% | — | — | |
| Q2 2014 | -1.2% | — | — | |
| Q1 2014 | -1.6% | — | — | |
| Q4 2013 | +1.1% | — | — | |
| Q3 2013 | -2.5% | — | — | |
| Q2 2013 | -3.9% | — | — | |
| Q1 2013 | +0.7% | — | — | |
| Q4 2012 | -1.8% | — | — | |
| Q3 2012 | -2.5% | — | — | |
| Q2 2012 | -0.9% | — | — | |
| Q1 2012 | -4.0% | — | — | |
| Q1 2011 | -4.0% | — | — | |
| Q4 2009 | +1.1% | — | — | |
| Q4 2011 | +1.1% | — | — | |
| Q3 2011 | -2.9% | — | — | |
| Q4 2010 | +3.4% | — | — | |
| Q2 2011 | +3.4% | — | — | |
| Q3 2010 | -6.4% | — | — | |
| Q2 2010 | -0.9% | — | — | |
| Q1 2010 | -6.7% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro